阿佩林受体二次体:分类,未来前景,以及病理生理学的观点
Shujuan Hu1, Dexiu Wang1, Wenkai Liu1
1School of Basic Medical Sciences, Shandong Second Medical University, Weifang, Shandong 261042, PR China.
概括
阿林受体 (APJ) 形成调节心血管和神经系统功能的二元体. APJ二元体显示出作为神经保护剂和血管痴呆症的药物点的潜力.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 阿佩林受体 (APJ) 是一种G蛋白结合受体 (GPCR),对心血管和中枢神经系统的调节至关重要.
- APJ功能障碍与高血压,动脉样硬化和中风等疾病有关,突出显示了其治疗潜力.
- 初步数据表明,APJ存在于单体和各种寡合体形式 (二元体,高阶寡合体).
研究的目的:
- 为了回顾阿佩林受体 (APJ) 二次体的结构特征.
- 阐明APJ二次体的生理和病理作用.
- 探索APJ二聚合物的药理应用.
主要方法:
- 对APJ结构和功能研究的文献综述.
- 对APJ寡合化和信号通路的研究分析.
- 综合与疾病状态中的APJ二次体相关的发现.
主要成果:
- APJ可以形成同质体,异质体和高阶寡质体.
- 这些寡合体形式与单体相比,参与不同的信号通路.
- APJ同位体表现出神经保护作用,特别适用于血管痴呆症.
结论:
- APJ二元化是其多样化的生理和病理作用的关键因素.
- APJ二元体代表了血管痴呆和其他神经系统疾病的有希望的治疗点.
- 对APJ寡合化的进一步研究可能会释放新的药物开发战略.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Transducer Mechanism: G Protein–Coupled Receptors
1.9K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
1.9K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
Adrenergic Receptors: ɑ Subtype
1.5K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.5K
Adrenergic Receptors (Adrenoceptors): Classification
2.5K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
2.5K


